Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.

Biotechnology

Enara Bio

Anonymous

Adam Taylor

Jonathan Porter

Sophie Papa

Duncan Howie

Andrew Fadden

Luke Williams

Ray Duffy

Simon Jarvis

Jo Senra

Bethany Turner

Nicola Ternette

Fabio Marino

Charlotte Howard

Joseph Dukes

David Watson

Research and Development

Directors

Leadership Team

Scientific Advisory Board

Teams at Enara Bio

Research and Development

Directors

Leadership Team

Scientific Advisory Board